Thalys Medical Technology Group

Thalys Medical Technology Group EBIT Margin

The EBIT Margin (Operating Margin) of Thalys Medical Technology Group (603716.SS) as of Oct 30, 2026 is -5.39 %. In the previous year, EBIT Margin (Operating Margin) was -4.97 % — a change of 8.50% (lower).

EBIT Margin

-5.39 %

YoY

8.50%

Last updated:

EBIT Margin (Operating Margin) of Thalys Medical Technology Group is 2025 -5.39 % . EBIT Margin (Operating Margin) of Thalys Medical Technology Group was 2024 -4.97 % . It decreases by 8.50% lower compared to the previous year.

Thalys Medical Technology Group's operating (EBIT) margin stands at -5.4%, down from 2.3% several years earlier.

The Thalys Medical Technology Group EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
12.04 CNY
Jan 1, 2019
10.24 CNY
Jan 1, 2020
5.50 CNY
Jan 1, 2021
2.34 CNY
Jan 1, 2022
-3.97 CNY
Jan 1, 2023
-5.80 CNY
Jan 1, 2024
-4.97 CNY
Jan 1, 2025
-5.39 CNY
The Thalys Medical Technology Group EBIT Margin history
YEAREBIT MarginYoY
-5.39 %+8.50%
-4.97 %-14.33%
-5.80 %+46.10%
-3.97 %-269.54%
2.34 %-57.45%
5.50 %-46.27%
10.24 %-14.96%
12.04 %-25.61%
16.19 %-0.97%
16.34 %+4.14%
15.69 %-8.26%
17.11 %+9,818.68%
0.17 %-9.25%
0.19 %-26.53%
0.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Thalys Medical Technology Group Stock analysis

What does Thalys Medical Technology Group do? Thalys Medical Technology Group Corp, based in Wuhan, China, operates in the Health Care sector with a focus on Biotechnology. The company develops, produces, and sells in vitro diagnostic products, including reagents, consumables, and equipment. It serves major domestic markets such as Hubei, Hunan, Jiangsu, Henan, and Shanghai, employing 1,474 full-time staff. Listed on October 31, 2016, Thalys specializes in diagnostic solutions for the Chinese healthcare market. Thalys Medical Technology Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Thalys Medical Technology Group stock

EBIT Margin (Operating Margin) of Thalys Medical Technology Group is -5.39 % in 2025.

EBIT Margin (Operating Margin) of Thalys Medical Technology Group changed from -4.97 % to -5.39 %, representing a 8.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Thalys Medical Technology Group since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Thalys Medical Technology Group with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Thalys Medical Technology Group

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Thalys Medical Technology Group